Skip to main content
. 2022 Nov 17;2022(11):CD014963. doi: 10.1002/14651858.CD014963.pub2

3.3. Analysis.

3.3

Comparison 3: Subgroup analysis: dexamethasone versus methylprednisolone versus hydrocortisone for the comparison of corticosteroids plus standard care versus standard care (plus/minus placebo) for hospitalised individuals with a confirmed or suspected diagnosis of symptomatic COVID‐19, Outcome 3: Clinical improvement: discharged alive